David smith, British professional wrestler

Scientists at the University of York have made significant progress in the development of a nasal spray treatment for patients with Parkinson's disease.Researchers have developed a new gel that can adhere to tissue inside the nose alongside the drug levodopa, helping deliver treatment directly to the brain.Levodopa is converted to dopamine in the brain, which makes up for the deficit of dopamine-producing cells in Parkinson's patients, and helps treat the symptoms of the disease.Overextended periods of time, however, levodopa becomes less effective, and increased doses are needed.Professor David Smith, from the University of York's Department of Chemistry, said: "The current drug used for Parkinson's Disease is effective to a point, but after a long period of use the body starts to breakdown the drug before it gets to the brain where it is most needed."This means the increased dosage is necessary, and in later stages, sometimes, instead of tablets, the drug has to be injected. Investigations into nasal sprays have long been of interest as a more effective delivery because of its direct route to the brain via the nerves that service the nose, but the challenge here is to find a way of making it adhere to the nasal tissue long enough to release a good dosage of the drug."The researchers created a gel, loaded with levodopa, that could flow into the nose as a liquid and then rapidly change to a thin layer of gel inside the nose. The method was tested in animal models by a team at King's College London, where levodopa was successfully released from the gel into the blood and directly to the brain.Professor Smith said: "The results indicated that the gel gave the drug better adhesion inside the nose, which allowed for better levels of uptake into both the blood and brain."The team are now working to incorporate these materials in nasal spray devices to progress to clinical trials in humans. The approach may also be relevant to other neurodegenerative diseases such as Alzheimer's.Khuloud Al-Jamal, Professor of Drug Delivery and Nanomedicine from King's College London, said: "Not only did the gel perform better than a simple solution, but the brain uptake was better than that achieved using intravenous injection of the drug. This suggests that nasal delivery of Parkinson's drugs using this type of gel may have clinical relevance."( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

David Smith, NewsFOLLOW

David smith, Latest News

Business :Maximising product and minimising waste with innovative packaging: Inventors from MIT selected as finalists for the European Inventor Award 2023

New Delhi [India], May 9 (/BusinessWire India): The United Nations estimates that approximately 36 per cent of all plastics ... ...

International :British national suspected of spying for Russia charged with espionage

A security guard for the British embassy in Berlin suspected of working for the Russian intelligence services has been charged with nine offences under the UK Official Secrets Act. ...

International :British-Indian writer launches Modi monograph at Sharjah Book Fair

Sharjah, Nov 12 A 62-page monograph on Indian Prime Minister Narendra Modi, originally launched in the UK in ... ...

Health :Aussie essential workers toil to keep Sydney going during lockdown

Sydney, Aug 18 There is little doubt that essential workers have kept the wheels of Australia's largest city ... ...

Technology :Researchers get step-closer to nasal spray drug delivery for Parkinson's disease

Scientists at the University of York have made significant progress in the development of a nasal spray treatment for patients with Parkinson's disease. ...